News

The IIBB is a beneficiary partner of the HORIZON-HLTH-2022- EU Project HALT-RONIN (Halt-Chronic Inflammation).

The HORIZON-HLTH-2022-STAYHLTH-02/101095679 project entitled: “Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH transition to inform early prevention an

Read More

Found a genetic mechanism involved in a multisystem inflammatory syndrome that aggravates Covid-19 in some children

A team of researchers, including Dr. Anna Planas from the IIBB-CSIC, has found a genetic mechanism involved in a type of exaggerated immune reaction that aggravates covid-19 in some children.

Read More

Nanoparticles for gene therapy directed to cellular targets in the brain

  • A collaborative research work patents a gene therapy procedure based on liposomal nanoparticles, successfully tested in rodents, capable of delivering therapeutic oligonucleotides directly to
Read More

INTERNATIONAL SYMPOSIUM “LIPID SIGNALIG AND OXIDATIVE STRESS IN PATHOLOGY”

The research group "Mitochondrial regulation of cell death" of the IIBB organizes an International Symposium on cell signaling by lipids and its impact on oxidative stress and human pathology to be

Read More

TV3 echoes the research led by the Biological and Environmental Proteomics group of the IIBB

Last November 18, the TV3 program "Tot es mou" went to the laboratory of the Biological and Environmental Proteomics group of the IIBB to interview Dra.

Read More

La Marató de TV3 has granted a research project to IIBB researcher Analía Bortolozzi

On November 3, 2022, the Board of Trustees of La Marató de TV3 Foundation has agreed to award a grant to Dr.

Read More

JAE Intro 2022 Scholarships

The IIBB offers opportunities to join groups as part of the JAE Intro scholarship call for the year 2022.

Read More

Pages